Registration
REGISTER FOR THE CONFERENCE
Apply to Exhibit
APPLICATION FOR EXHIBITION
Sponsorship
SPONSORSHIP APPLICATION
Two US Companies Partner to Bring AI to Nuclear Power Plant Simulation Training
Nuclearn, a US artificial intelligence solutions company, and GSE Solutions, a supplier of high-fidelity simulation and operator training systems for nuclear power plants, announced a strategic partnership on August 20. The two companies will combine Nuclearn's AI capabilities with GSE Solutions' nuclear power plant simulator technology for applications such as plant simulation, operator training, and engineering analysis. According to information released by the two companies, the collaboration will proceed along two tracks. GSE Solutions plans to integrate Nuclearn's AI features into its simulator products, providing training instructors with tools such as natural language scenario development, automatic performance summaries after training scenarios, adaptive quiz and assessment generation, and plant-specific physics explanations during training...
2026-08-21
U.S. Apollo Atomics Secures $31 Million in Funding to Advance Commercialization of Compact Pressurized Water Reactor
2026-08-21
South Korea Approves License Amendment for Gyeongju Low- and Intermediate-Level Radioactive Waste Disposal Facility
2026-08-21
South Korea's DaeChang Solution Secures Special Steel Contract for French Nuclear Power Turbines
2026-08-21
Bulgaria's Kozloduy NPP Reduces Power Output Due to Falling Danube River Levels
2026-08-21
US Standard Nuclear and Radiant Sign TRISO Fuel Supply Agreement
2026-08-21
US LIS Technologies Initiates Site Preparation for Oak Ridge Laser Uranium Enrichment Project
2026-08-21
Takahama Town in Fukui Prefecture, Japan, Plans to Give Prior Consent to Kansai Electric Power's Construction of Spent Fuel Dry Storage Facility
2026-08-21
Kyushu Electric Power explains holding company transition to Kagoshima Prefecture; Sendai Nuclear Power Plant business to continue
2026-08-21
On August 17, Luo Xu, General Manager of Atom High-Tech, and Liu Wen, Chairman of CNNC Headway, led a delegation to Tsinghua University for a business cooperation exchange with the School of Biomedical Engineering. Hu Ye, Dean of the School of Biomedical Engineering, and Ma Kai, Associate Professor of the School, attended the exchange. The visit aimed to leverage the research and talent advantages of a top-tier university, promote deep integration of industry, academia, and research, and jointly explore new cooperation opportunities in the fields of nuclear medicine and biomedical engineering. During the exchange meeting, Atom High-Tech and CNNC Headway respectively introduced their corporate development histories, core business layouts, and future strategic plans. Subsequently, Dean Hu Ye and Associate Professor Ma Kai respectively introduced...
2026-08-21
Following the institutional partnership established between CEPID CancerThera and the Uruguayan Center for Molecular Imaging (CUDIM) in February this year, a Brazilian delegation visited Montevideo, Uruguay, from July 27 to 29 to advance the transformation of the memorandum of understanding into a concrete work plan. The visit focused on multicenter clinical trials, preclinical research, theranostics in oncology, and educational cooperation. During the visit, Brazilian researchers held working meetings with the CUDIM team, covering multiple aspects of oncology research development. CUDIM was represented by its General Director Alarico Rodriguez, as well as radiopharmacist and Technical Director of Radiopharmacy, Dr. Eduardo Osvaldo Savio Queve...
2026-08-20
Akiram Therapeutics, a Swedish clinical-stage biotechnology company, and ITM Isotope Technologies Munich SE, a German radiopharmaceutical biotechnology company, recently announced the signing of a supply agreement. Under the agreement, ITM will supply no-carrier-added lutetium-177 (nca Lu-177) to Akiram to support the clinical development of its targeted antibody-radionuclide conjugate, 177Lu-AKIR001 (AKIR001). AKIR001 is Akiram's lead radiopharmaceutical candidate, currently being investigated in clinical studies for the treatment of CD44v6-expressing solid tumors. The candidate combines the therapeutic radioisotope nca Lu-177 with a proprietary antibody targeting CD44v6. CD...
2026-08-20
Recently, the automatic radiation environment monitoring station located within the Nuclear Medical Health Industrial Park of the China (Mianyang) Science and Technology City was officially put into trial operation. As the first automatic radiation environment monitoring station in Sichuan Province to fully achieve domestic localization of core equipment and systems, it will provide radiation environment safety assurance for the development of the nuclear medical industry in the park through 24-hour uninterrupted automatic monitoring capabilities. At the automatic radiation environment monitoring station, operational data from equipment such as environmental γ dose rate monitors are updated in real time on monitoring screens. Compared with the previous approach that relied on manual on-site sampling and batch laboratory analysis, the automatic station enables continuous monitoring, reducing the time required to produce monitoring results from several days to the same day, thereby improving...
2026-08-20
Full-Life Technologies (hereinafter referred to as "Full-Life"), a privately held, fully integrated, clinical-stage international radiopharmaceutical therapy company, announced on August 20 that its radiopharmaceutical production facility in Gembloux, Belgium, has completed construction and received authorization to commence accelerator commissioning and enter the initial ramp-up phase. (Full-Life Technologies Belgium Radiopharmaceutical Production Facility) This milestone marks a significant step forward in Full-Life's vertically integrated radioisotope production capabilities moving toward formal operational status. With the completion of facility construction, the company has entered the next phase of operational preparation, including accelerator installation, phased commissioning, and validation of critical safety and operational systems.
2026-08-20
The U.S. Department of Energy's Lawrence Berkeley National Laboratory and Ideon Technologies have received funding from the DOE's Advanced Research Projects Agency-Energy (ARPA-E) to jointly develop a field-deployable active-source muon imaging technology through the Reliable Ore Characterization Using Cornerstone Sensing Technologies (ROCKS) program. The three-year project aims to enhance the detection and characterization of underground critical mineral resources. Image credit: Lawrence Berkeley National Laboratory. Muons are subatomic particles with strong penetrating capability. Previously, Ideon Technologies has used passive muons produced by cosmic rays in the atmosphere for ore body imaging in the mining sector, mapping mineral deposits and analyzing subsurface structures. However, passive muons primarily arrive from above, limiting detection angles; additionally, the natural flux is low—approximately one per square centimeter per minute—and imaging often requires days, weeks, or even months.
2026-08-20
Jeonbuk National University announced on the 20th that a research team led by Professor Bae Hak-yeol from the Department of Electronic Engineering at its College of Engineering, in collaboration with Professor Kim Tae-wan's team at Seoul National University and Q-Beam Solution, a startup affiliated with the Korea Atomic Energy Research Institute, conducted a joint study analyzing the causes of performance degradation in next-generation ferroelectric memory and neuromorphic semiconductor devices under neutron irradiation. The findings have been published in the latest issue of ACS Applied Electronic Materials. Ferroelectric semiconductors, which can maintain their polarization state even after power is disconnected, are considered a key candidate for next-generation non-volatile memory and neuromorphic computing devices. Neuromorphic computing aims to simultaneously implement both memory and computation within a single device...
2026-08-20
